| Net Cash Provided by (Used in) Operating Activities |
$18,764 |
USD |
76% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$3,613 |
USD |
-105% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
50,389,011 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$22,377 |
USD |
-2176% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$93,388 |
USD |
|
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Valuation Allowance |
$919,037 |
USD |
40% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$919,037 |
USD |
40% |
Q4 2024 |
FY 2024 |
| Depreciation |
$78,361 |
USD |
1161% |
Q1 2024 |
Q1 2024 |
| Property, Plant and Equipment, Gross |
$138,782 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$985,963 |
USD |
39% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$4,806,201 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$826,638 |
USD |
-10% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$91,202 |
USD |
-30% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |